Interestingly, the addition of metformin, an insulin sensitizer, inhibits tumor cell proliferation, which is associated with the activation of the adenosine monophosphate kinase pathway in cells and subsequent inhibition of the mammalian target rapamycin (mTOR) pathway. The gene discussed is MTOR; the disease is neoplasm.